European Journal of Pharmaceutics and Biopharmaceutics

Papers
(The H4-Index of European Journal of Pharmaceutics and Biopharmaceutics is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Editorial Board125
Authors’ reply to comments on “Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt”124
Comparison of barrier properties of outer blood-retinal barrier models – Human stem cell-based models as a novel tool for ocular drug discovery116
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions116
Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study98
Double-layer dissolving microneedles for delivery of mesenchymal stem cell Secretome: Formulation, characterisation and skin irritation study92
Editorial Board86
Editorial Board75
Long-term exposure in high viscous microenvironment facilitates acquired drug resistance of colon cancer cells to doxorubicin68
Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response58
Unravelling the polysorbate 20 composition: A fusion of UPLC-MS analysis and stochastic modelling57
Corrigendum to “Extracellular vesicles delivered rapamycin to improve the tumor microenvironment and enhance hepatocellular carcinoma immunotherapy” [Eur. J. Pharm. Biopharm. 211 (2025) 114714]55
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration51
Viscosity increase/gelation of therapeutic IgG monoclonal antibodies induced by Zn2+: One possible root cause of clogging of staked-in-needle prefilled syringes49
Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells48
Simplified choice of suitable excipients within biologics formulation design using protein-protein interaction- and water activity-maps47
Strain- and species-specific immune responses to human adipose stem cell-derived extracellular vesicles: A comparative pharmacological evaluation in mice and human PBMCs46
Rationalisation of the purification process for a phage active pharmaceutical ingredient45
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles44
COSMO models for the pharmaceutical development of parenteral drug formulations44
Liquid crystal phase formation and non-Newtonian behavior of oligonucleotide formulations43
Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids42
In-situ sequential crystallization of fenofibrate and tristearin – Understanding the distribution of API in particles and stability of solid lipid microparticles from the perspective of crystallizatio42
Topical liquid formulation of bacteriophages for metered-dose spray delivery40
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment39
Homogeneity and mechanical properties of orodispersible films loaded with pellets38
Impact of post approval quantitative changes in excipient composition on nitrosamine formation: De-risking strategy38
Impact of various factors on the kinetics of non-enzymatic fragmentation of a monoclonal antibody38
Harnessing dicarboxylate-based salts for enhancing the performance of amorphous solid dispersions: The case of olanzapine38
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans36
Editorial Board36
Question-based review for pharmaceutical development: An enhanced quality approach36
Nose-to-Brain delivery of genistein-loaded peppermint lipid nanocapsules for neuroprotection against Alzheimer’s Disease: Formulation, Characterization, pharmacokinetic and Pharmacodynamic studies36
Stearic acid-capped mesoporous silica microparticles as novel needle-like-structured drug delivery carriers35
Effect of the combination of ion-pairs strategies and permeation enhancers on iguratimod transdermal patch against rheumatoid arthritis35
Release profiles prediction of diclofenac sodium patches using Raman mapping technique35
1.0641140937805